3-49241388-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001135197.2(IHO1):āc.394A>Gā(p.Ser132Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000503 in 1,608,958 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.000054 ( 1 hom. )
Consequence
IHO1
NM_001135197.2 missense, splice_region
NM_001135197.2 missense, splice_region
Scores
7
11
Splicing: ADA: 0.9904
2
Clinical Significance
Conservation
PhyloP100: 4.58
Genes affected
IHO1 (HGNC:27945): (interactor of HORMAD1 1) Predicted to be involved in gamete generation; meiosis I cell cycle process; and regulation of homologous chromosome segregation. Predicted to be active in condensed nuclear chromosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IHO1 | NM_001135197.2 | c.394A>G | p.Ser132Gly | missense_variant, splice_region_variant | 4/8 | ENST00000452691.7 | NP_001128669.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IHO1 | ENST00000452691.7 | c.394A>G | p.Ser132Gly | missense_variant, splice_region_variant | 4/8 | 2 | NM_001135197.2 | ENSP00000407837.2 | ||
IHO1 | ENST00000296449.9 | c.394A>G | p.Ser132Gly | missense_variant, splice_region_variant | 6/10 | 1 | ENSP00000296449.5 | |||
IHO1 | ENST00000438782.5 | c.394A>G | p.Ser132Gly | missense_variant, splice_region_variant | 4/8 | 5 | ENSP00000391788.1 | |||
IHO1 | ENST00000366429.2 | c.394A>G | p.Ser132Gly | missense_variant, splice_region_variant | 4/5 | 2 | ENSP00000403700.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000118 AC: 29AN: 245126Hom.: 1 AF XY: 0.000181 AC XY: 24AN XY: 132716
GnomAD3 exomes
AF:
AC:
29
AN:
245126
Hom.:
AF XY:
AC XY:
24
AN XY:
132716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000535 AC: 78AN: 1456752Hom.: 1 Cov.: 30 AF XY: 0.0000800 AC XY: 58AN XY: 724606
GnomAD4 exome
AF:
AC:
78
AN:
1456752
Hom.:
Cov.:
30
AF XY:
AC XY:
58
AN XY:
724606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74372
GnomAD4 genome
AF:
AC:
3
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
19
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2023 | The c.394A>G (p.S132G) alteration is located in exon 6 (coding exon 3) of the CCDC36 gene. This alteration results from a A to G substitution at nucleotide position 394, causing the serine (S) at amino acid position 132 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
T;T;T;D
Polyphen
D;D;D;P
Vest4
MutPred
Gain of glycosylation at Y136 (P = 0.0043);Gain of glycosylation at Y136 (P = 0.0043);Gain of glycosylation at Y136 (P = 0.0043);Gain of glycosylation at Y136 (P = 0.0043);
MVP
MPC
0.54
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at